Washington University
Researchers Stress Specificity of Grail Multi-Cancer Detection Test in Response to Study Criticism
Premium
The authors of a commentary said they view recent study results as informative, though limited, regarding the test's performance in prostate cancer.
The biomarker p-tau 217 best correlated with other established signs of Alzheimer's disease in a head-to-head study evaluating six blood-based assays.
Hospitals Figuring Out How to Incorporate Beta-Amyloid Testing in Standard Clinical Practice
Premium
Spurred by newly available beta-amyloid-targeting drugs, hospitals are exploring how to diagnose Alzheimer's patients early and determine their treatment.
Two blood-based biomarkers, percentage of p-tau 217 and amyloid-beta 42/40 ratio, predicted the presence of beta-amyloid plaque in patients' PET scans.
At AAIC, researchers showed the potential of long-term treatments with Roche’s gantenerumab in patients likely to develop dominantly inherited Alzheimer's.